PATENT CLAIM ANALYSIS

Application Number: 15864990
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["424", "423000"]

Abstract:
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants can be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, including reduction of an elevated intraocular pressure.

Claim (Index 1):
A method for treating macular degeneration comprising the step of intraocular administration of a biodegradable intraocular implant comprising:\n (a) about 50 weight percent brimonidine, and; (b) a biodegradable polymer which is a mixture of:\n (i) an acid end capped polymer (D,L-lactide) polymer, and \n (ii) a poly (D,L-lactide-co-glycolide) polymer; and \n wherein the total weight of the biodegradable intraocular implant is between 250 \u03bcg and 5000 \u03bcg.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 1.84314
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14816401', '15383079', '12272548', '11394765', '11119021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7633345780170803
- 35 USC 102 Novelty (BERT): 0.5786619826243302
- Combined Prediction Score: 0.7448673184778053
- Mean Citation Score: 451.717918
- Max Citation Score: 489.43768
- Similarity Product: 393.8100176148319

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test